Group 1 - The company Zhonghui Biotech-B (02627) announced the results of its share placement, with a total global offering of 33.4426 million shares [1] - The Hong Kong public offering accounted for 11.95% of the total, while the international offering made up 88.05% [1] - The final offer price was set at HKD 12.9 per share, resulting in net proceeds of approximately HKD 383 million from the global offering [1] Group 2 - The Hong Kong public offering was oversubscribed by 4007.64 times, indicating strong demand [1] - The international offering had a subscription rate of 0.99 times, reflecting a lower demand compared to the public offering [1] - The H-shares are expected to commence trading on the Hong Kong Stock Exchange on August 11, 2025, at 9:00 AM Hong Kong time [1]
中慧生物-B(02627)香港公开发售获4007.64倍认购 每股发售价12.9港元